<qa>  What is the Phase II Group 3?- Phase II Group 3 EGFRmut, T790M negative, any c-MET, 1L antineoplastic only: patients must harbor an EGFR activating mutation and must be naïve from any line of systemic antineoplastic therapy in the advanced setting. 